Korean Drug Company Overview
- Year Founded
-
1980
- Status
-
Public
- Employees
-
245
- Stock Symbol
-
014570
- Share Price
-
$3.50
- (As of Monday Closing)
Korean Drug Company General Information
Description
Korean Drug Co Ltd is engaged in manufacturing and marketing of pharmaceutical products in South Korea. Its products portfolio consists of over-the-counter (OTC) medicines, ethical (ETC) medicines and health food.
Contact Information
Website
www.nicepharma.comCorporate Office
- 34 Nonhyeon-ro 28-gil, Gangnam-gu
- Seoul
- South Korea
Corporate Office
- 34 Nonhyeon-ro 28-gil, Gangnam-gu
- Seoul
- South Korea
Korean Drug Company Stock Performance
As of 14-Jul-2025, Korean Drug Company’s stock price is $3.50. Its current market cap is $37.8M with 10.8M shares.
(As of Monday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $3.50 | $3.50 | $2.87 - $4.59 | $37.8M | 10.8M | 13K | $0.03 |
Korean Drug Company Financials Summary
As of 31-Mar-2025, Korean Drug Company has a trailing 12-month revenue of $47.9M.
|
In Thousands, USD |
TTM 31-Mar-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 |
|---|---|---|---|---|
| EV | 15,368 | 20,893 | 32,878 | 44,950 |
| Revenue | 47,870 | 53,503 | 62,239 | 61,902 |
| EBITDA | 2,434 | 4,743 | 6,734 | 11,956 |
| Net Income | 321 | 2,195 | (3,761) | 9,139 |
| Total Assets | 61,773 | 60,346 | 69,613 | 74,840 |
| Total Debt | 46 | 55 | 52 | 64 |
Korean Drug Company Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Korean Drug Company Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Korean Drug Company Patents
Korean Drug Company Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-7339698-B2 | Antithrombotic composition containing noseri extract and antithrombotic agent | Active | 18-Oct-2017 | ||
| JP-2020537696-A | Antithrombotic composition containing wild auction extract and antithrombotic agent | Pending | 18-Oct-2017 | ||
| JP-2022062186-A | Antithrombotic composition containing wild auction extract and antithrombotic agent | Active | 18-Oct-2017 | ||
| EP-3698804-A2 | Antithrombotic composition containing wild parsley extract and antithrombotic agent | Pending | 18-Oct-2017 | ||
| EP-3698804-A4 | Antithrombotic composition containing wild parsley extract and antithrombotic agent | Pending | 18-Oct-2017 | A61K36/23 |
Korean Drug Company Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Korean Drug Company FAQs
-
When was Korean Drug Company founded?
Korean Drug Company was founded in 1980.
-
Where is Korean Drug Company headquartered?
Korean Drug Company is headquartered in Seoul, South Korea.
-
What is the size of Korean Drug Company?
Korean Drug Company has 245 total employees.
-
What industry is Korean Drug Company in?
Korean Drug Company’s primary industry is Pharmaceuticals.
-
Is Korean Drug Company a private or public company?
Korean Drug Company is a Public company.
-
What is Korean Drug Company’s stock symbol?
The ticker symbol for Korean Drug Company is 014570.
-
What is the current stock price of Korean Drug Company?
As of 14-Jul-2025 the stock price of Korean Drug Company is $3.50.
-
What is the current market cap of Korean Drug Company?
The current market capitalization of Korean Drug Company is $37.8M.
-
What is Korean Drug Company’s current revenue?
The trailing twelve month revenue for Korean Drug Company is $47.9M.
-
What is Korean Drug Company’s annual earnings per share (EPS)?
Korean Drug Company’s EPS for 12 months was $0.03.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
